Lanifibranor Improves Markers of Cardiometabolic Health in Patients with NASH and Type 2 Diabetes, Correlated with Responses in Adiponectin Levels

Griffel, LH; Francque, S; Abdelmalek, MF; Huot-Marchand, P; Dzen, L; Baudin, M; Junien, JL; Broqua, P; Cooreman, MP

DIABETES, 2023; 72 ():